Posts - Bill - S 1587 Fair Prescription Drug Prices for Americans Act
senate 05/05/2025 - 119th Congress
We are working to ensure that prescription drug prices in the U.S. do not exceed the average prices paid in other major countries like Canada, France, and Japan. This legislation aims to make medications more affordable by capping U.S. retail list prices based on international benchmarks.
Congress.gov
S 1587 - Fair Prescription Drug Prices for Americans Act
Views
left-leaning 05/05/2025
Capping drug prices to global averages? About time we treat healthcare like a right, not a luxury.
moderate 05/05/2025
Matching international prices sounds fair, but let’s watch closely for any supply hiccups or innovation slowdowns.
left-leaning 05/05/2025
Why pay more in the U.S. when Canada and Europe show us how to do it right? This bill’s a win for every paycheck.
left-leaning 05/05/2025
Finally, a bill that puts Big Pharma's greed on a leash—because Americans shouldn't pay a global premium for their meds.
moderate 05/05/2025
Capping prices is tempting, but the devil’s in the details; let’s hold manufacturers accountable without killing the golden goose.
right-leaning 05/05/2025
Mandating global price averages is a stealth tax on drug companies that fuels less research, not more care.
moderate 05/05/2025
A smart move if it actually lowers costs without killing investment—balance is key here, folks.
right-leaning 05/05/2025
Let the free market breathe; this bill’s just another handout disguised as control, and American ingenuity pays the price.
right-leaning 05/05/2025
Price caps? Next thing you know, government’s running the pharmacy—say goodbye to innovation and hello to shortages.